Stoke Therapeutics, Inc. (STOK) Total liabilities 2022–2025
Stoke Therapeutics, Inc. (STOK) total liabilities at each fiscal year-end, per SEC filings.
$66.0MFY2025 · since FY2022: $71.2M → $66.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $66.0M | +55.1% |
| FY2024 | $42.5M | -38.2% |
| FY2023 | $68.8M | -3.4% |
| FY2022 | $71.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More STOK financial trends
STOK RevenueSTOK Net incomeSTOK Net marginSTOK Gross profitSTOK Gross marginSTOK Operating incomeSTOK Operating marginSTOK Operating cash flowSTOK Free cash flowSTOK Capital expendituresSTOK Return on equitySTOK Stock buybacksSTOK Dividends paidSTOK Total assetsSTOK Shareholders’ equitySTOK overview →